1. Salih AE, Elsherif M, Ali M, Vahdati N, Yetisen AK, Butt H. Ophthalmic Wearable Devices for Color Blindness Management. Advanced Materials Technologies. 2020;5(8):1901134.
2. Yang Z, Yan L, Zhang W, Qi J, An W, Yao K. Dyschromatopsia: a comprehensive analysis of mechanisms and cutting-edge treatments for color vision deficiency. Front Neurosci. 2024 Jan 17;18:1265630.
3. Yasa AT. Colour Vision Deficiency: Difference Between Congenital and Acquired Colour Blindness. Jurnal Kedokteran, 2022. 11(3), 1021–1027. https://doi.org/10.29303/jku.v11i3.735
7. Carroll J, Conway BR. Chapter 8 - Color vision. In: Barton JJS, Leff A, editors. Handbook of Clinical Neurology. Elsevier; 2021. p. 131–53. (Neurology of Vision and Visual Disorders; vol. 178).
8. Neitz M, Neitz J. Intermixing the OPN1LW and OPN1MW Genes Disrupts the Exonic Splicing Code Causing an Array of Vision Disorders. Genes. 2021 Aug;12(8):1180.
9. Hasrod N, Rubin A. Defects of colour vision: A review of congenital and acquired colour vision deficiencies. AVEH, 2016. https://avehjournal.org/index.php/aveh/article/view/365/648
10. Brunetti-Pierri R, Karali M, Melillo P, Di Iorio V, De Benedictis A, Iaccarino G, et al. Clinical and Molecular Characterization of Achromatopsia Patients: A Longitudinal Study. International Journal of Molecular Sciences. 2021 Jan;22(4):1681.
15. Felden J, Baumann B, Ali M, Audo I, Ayuso C, Bocquet B, et al. Mutation spectrum and clinical investigation of achromatopsia patients with mutations in the GNAT2 gene. Human Mutation. 2019;40(8):1145–55.
16. Osman S, Khalaf S, Mohammed H, El-Sebaity D, Osman D. Prevalence and predictors of colour vision defects among Egyptian university students. East Mediterr Health J. 2021 Apr 27;27(4):399–406.